Spermatocytic tumour, once called spermatocytic seminoma, is a rare testicular germ cell tumour of older men that arises from maturing sperm precursors rather than from the fetal germ cells behind ordinary testicular cancer. It almost never spreads, so removing the testis is the whole treatment and no chemotherapy or radiotherapy is needed.
The 2016 WHO classification renamed spermatocytic seminoma as spermatocytic tumour and placed it among the germ cell tumours unrelated to germ cell neoplasia in situ, because it derives from postpubertal spermatogonia rather than from the arrested fetal germ cells that give rise to seminoma and non-seminoma (Moch 2016). Marker studies identified two types characterised by OCT2 or SSX2-4 expression, corresponding to distinct spermatogonial subpopulations, supporting a spermatogonial stem cell origin (Journal of Pathology 2011). In the Australian registry study it made up 1.1 percent of seminomas, with a mean age of 53.5 but a range from 19 to 92, occurring as often under 55 as over (Journal of Urology 2007).
How it differs from its parent: it lacks isochromosome 12p and germ cell neoplasia in situ, is not associated with cryptorchidism or the other risk factors of testicular cancer, does not raise the serum markers, and metastasises almost never except in the rare sarcomatous transformation, so the surveillance and chemotherapy pathways of seminoma do not apply.
How common: 0.4 per million men a year (Journal of Urology 2007).
Treatment: radical orchidectomy alone, with no adjuvant therapy and no routine retroperitoneal imaging beyond a baseline scan; the rare tumour with sarcomatous transformation is treated as a sarcoma.
58 of 9,658 primary malignant testicular tumours in Australia over 1982 to 2002, 1.1 percent of all seminomas, an age-standardised incidence of 0.4 per million men a year; age 19 to 92, mean 53.5 (Journal of Urology 2007).
Germ cell tumours drain along the spermatic cord to the para-aortic nodes high in the abdomen, not to the groin, which is why staging scans look at the retroperitoneum.
Same organ: Retroperitoneal germ cell tumour, Leydig cell tumour of the testis, Sertoli cell tumour of the testis, Germ cell neoplasia in situ (GCNIS), Embryonal carcinoma of the testis, Yolk sac tumour of the testis, postpubertal type, Choriocarcinoma of the testis, Testicular germ cell tumours, Seminoma, Non-seminomatous germ cell tumour, Germ cell tumours of childhood and adolescence (extracranial and CNS)
No subtypes recorded beyond the ones named in the family strip above.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this cancer: (TITLE:"Spermatocytic tumour of the testis" OR ABSTRACT:"Spermatocytic tumour of the testis" OR TITLE:"Spermatocytic seminoma" OR ABSTRACT:"Spermatocytic seminoma" OR TITLE:"Spermatocytic tumour older men, indolent" OR ABSTRACT:"Spermatocytic tumour older men, indolent" OR TITLE:"Spermatocytic tumour older men, almost never metastasises" OR ABSTRACT:"Spermatocytic tumour older men, almost never metastasises" OR TITLE:"Spermatocytic tumor" OR ABSTRACT:"Spermatocytic tumor") AND (treatment OR therapy OR trial OR survival OR diagnosis). Results are unfiltered search hits about Spermatocytic tumour of the testis, not a curated reading list.
No targets or pathways are linked to this cancer yet. Browse the gene hub →
Cases by country, the UK and NHS pathway and other country lenses, and the expert centres with trials on record.
One section per setting: the options named, what each is for, the trials behind them, the recorded trade-offs and the questions to ask.
Newly diagnosed? Read the first 60 days with Spermatocytic tumour of the testis, then print the one-page appointment sheet with room for the answers.
Print this page for your appointment (your browser's print command). These prompts are for discussion; your clinical team knows your case.
Everything in development, the open problems and what is being done about them, the roadmaps, and what changed on this record.
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.